NEJM: Perspective on foodborne diseases
The Feb. 23 issue of The New England Journal of Medicine (NEJM) includes a perspective on foodborne disease. Read it at http://www.nejm.org/doi/full/10.1056/NEJMp1010907.
Web Exclusives
Nurses’ job dissatisfaction contributes to costly labor disputes, turnover, and risk to patients
Nurses’ job dissatisfaction contributes to costly labor disputes, turnover, and risk to patients according to a report in February’s Health Affairs. Read more here.
Older adults often closed out of clinical trials
More than half of clinical trials exclude older adults according to a study in the Journal of General Internal Medicine. Read more here.
Rand report calls for more action to prevent military suicide
“The War Within: Preventing Suicide in the U.S. Military,” a report released by the Rand Corporation, states U.S. military officials should improve their efforts…
FDA warning for terbutaline in preterm labor
The U.S. Food and Drug Administration issued a warning that terbutaline, indicated for asthma, bronchitis, and emphysema, should not be used in pregnant women…
FDA approves new drug for lupus
The U.S. Food and Drug Administration has approved Benlysta (belimumab) for treatment of lupus. The FDA last approved a drug for lupus in 1955.…
FDA approves new drug for COPD
The U.S. Food and Drug Administration has approved roflumilast, an oral drug that reduces exacerbations from severe chronic obstructive pulmonary disease (COPD). Read more…
Public-sector research in drugs and vaccines improves public health
A study in the New England Journal of Medicine reports, “Public-sector research has had a more immediate effect in improving public health than was…
Fidaxomicin reduces C. diff recurrence
Compared to vancomycin, patients treated with fidaxomicin for Clostridium difficile infection were significantly less likely to have a recurrence. Read more here.
FDA approves drug to reduce risk of preterm birth
The U.S. Food and Drug Administration (FDA) has approved Makena (hydroxyprogesterone caproate) injection to reduce the risk of preterm delivery in pregnant women with…
Can a nurse be too old to work at the bedside?
Read guest blogger Donna Cardillo’s thought-provoking article about when age comes into play during a nurse’s career. A recent New York Times article begged…
Emerging markets make gains in medical technology innovation
Emerging markets such as China, India, and Brazil are “gaining ground” in medical technology innovation and may surpass developed countries in innovative healthcare delivery…
NEJM: Perspective on foodborne diseases
The Feb. 23 issue of The New England Journal of Medicine (NEJM) includes a perspective on foodborne disease. Read it at http://www.nejm.org/doi/full/10.1056/NEJMp1010907.
Nurses’ job dissatisfaction contributes to costly labor disputes, turnover, and risk to patients
Nurses’ job dissatisfaction contributes to costly labor disputes, turnover, and risk to patients according to a report in February’s Health Affairs. Read…
Older adults often closed out of clinical trials
More than half of clinical trials exclude older adults according to a study in the Journal of General Internal Medicine. Read more…
Rand report calls for more action to prevent military suicide
“The War Within: Preventing Suicide in the U.S. Military,” a report released by the Rand Corporation, states U.S. military officials should improve…
FDA warning for terbutaline in preterm labor
The U.S. Food and Drug Administration issued a warning that terbutaline, indicated for asthma, bronchitis, and emphysema, should not be used in…
FDA approves new drug for lupus
The U.S. Food and Drug Administration has approved Benlysta (belimumab) for treatment of lupus. The FDA last approved a drug for lupus…
FDA approves new drug for COPD
The U.S. Food and Drug Administration has approved roflumilast, an oral drug that reduces exacerbations from severe chronic obstructive pulmonary disease (COPD).…
Public-sector research in drugs and vaccines improves public health
A study in the New England Journal of Medicine reports, “Public-sector research has had a more immediate effect in improving public health…
Fidaxomicin reduces C. diff recurrence
Compared to vancomycin, patients treated with fidaxomicin for Clostridium difficile infection were significantly less likely to have a recurrence. Read more here.
FDA approves drug to reduce risk of preterm birth
The U.S. Food and Drug Administration (FDA) has approved Makena (hydroxyprogesterone caproate) injection to reduce the risk of preterm delivery in pregnant…
Can a nurse be too old to work at the bedside?
Read guest blogger Donna Cardillo’s thought-provoking article about when age comes into play during a nurse’s career. A recent New York Times…
Emerging markets make gains in medical technology innovation
Emerging markets such as China, India, and Brazil are “gaining ground” in medical technology innovation and may surpass developed countries in innovative…
Get your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.
NurseLine Newsletter
*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.